Fatima Hayat
Company: Beacon Therapeutics
Job title: Cytokine Research Analyst
Seminars:
Innovative Strategies in TGF-β Therapy: Selective Targeting, Synergistic Combinations, and Cutting-Edge Modalities 3:30 pm
Demonstrating the use of bispecific antibodies and small molecule inhibitors to selectively block TGF-β oriented targets, reducing off-target effects and improving therapeutic outcomes Spotlighting the synergy between TGF-β inhibitors and immune checkpoint inhibitors in combination therapies to boost anti-tumor immunity, reduce systemic toxicity, and achieve superior clinical results in cancer and non-cancer therapy Highlighting the…Read more
day: Conference Day Two